Literature DB >> 23045494

Genome sequence of Acinetobacter baumannii AC12, a polymyxin-resistant strain isolated from Terengganu, Malaysia.

Han Ming Gan1, Soo-Sum Lean, Zarizal Suhaili, Kwai-Lin Thong, Chew Chieng Yeo.   

Abstract

Acinetobacter baumannii is a major cause of nosocomial infection worldwide. We report the draft genome sequence of A. baumannii AC12, a multidrug-resistant nosocomial strain with additional resistance to carbapenems and polymyxin. The genome data will provide insights into the genetic basis of antimicrobial resistance and its adaptive mechanism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23045494      PMCID: PMC3486123          DOI: 10.1128/JB.01466-12

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  14 in total

1.  Naturally transformable Acinetobacter sp. strain ADP1 belongs to the newly described species Acinetobacter baylyi.

Authors:  Mario Vaneechoutte; David M Young; L Nicholas Ornston; Thierry De Baere; Alexandr Nemec; Tanny Van Der Reijden; Emma Carr; Ingela Tjernberg; Lenie Dijkshoorn
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

2.  tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence.

Authors:  T M Lowe; S R Eddy
Journal:  Nucleic Acids Res       Date:  1997-03-01       Impact factor: 16.971

3.  Interspecies transformation of Acinetobacter: genetic evidence for a ubiquitous genus.

Authors:  E Juni
Journal:  J Bacteriol       Date:  1972-11       Impact factor: 3.490

4.  Isolation of Acinetobacter from soil and water.

Authors:  P Baumann
Journal:  J Bacteriol       Date:  1968-07       Impact factor: 3.490

5.  Rapid evolution of diminished transformability in Acinetobacter baylyi.

Authors:  Jamie M Bacher; David Metzgar; Valérie de Crécy-Lagard
Journal:  J Bacteriol       Date:  2006-10-06       Impact factor: 3.490

6.  The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A.

Authors:  Luis A Arroyo; Carmen M Herrera; Lucia Fernandez; Jessica V Hankins; M Stephen Trent; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2011-06-06       Impact factor: 5.191

7.  Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features.

Authors:  J M Cisneros; M J Reyes; J Pachón; B Becerril; F J Caballero; J L García-Garmendía; C Ortiz; A R Cobacho
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

Review 8.  Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.

Authors:  Lisa L Maragakis; Trish M Perl
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

9.  Blast2GO: a universal tool for annotation, visualization and analysis in functional genomics research.

Authors:  Ana Conesa; Stefan Götz; Juan Miguel García-Gómez; Javier Terol; Manuel Talón; Montserrat Robles
Journal:  Bioinformatics       Date:  2005-08-04       Impact factor: 6.937

10.  RNAmmer: consistent and rapid annotation of ribosomal RNA genes.

Authors:  Karin Lagesen; Peter Hallin; Einar Andreas Rødland; Hans-Henrik Staerfeldt; Torbjørn Rognes; David W Ussery
Journal:  Nucleic Acids Res       Date:  2007-04-22       Impact factor: 16.971

View more
  2 in total

1.  Characterization of carbapenem-resistant Acinetobacter baumannii isolates in a Chinese teaching hospital.

Authors:  Yaowen Chang; Guangxin Luan; Ying Xu; Yanhong Wang; Min Shen; Chi Zhang; Wei Zheng; Jinwei Huang; Jingni Yang; Xu Jia; Baodong Ling
Journal:  Front Microbiol       Date:  2015-09-01       Impact factor: 5.640

2.  Genome organisation of the Acinetobacter lytic phage ZZ1 and comparison with other T4-like Acinetobacter phages.

Authors:  Jing Jin; Zhen-Jiang Li; Shu-Wei Wang; Shan-Mei Wang; Song-Jian Chen; De-Hai Huang; Gai Zhang; Ya-Hui Li; Xiao-Ting Wang; Jin Wang; Guo-Qiang Zhao
Journal:  BMC Genomics       Date:  2014-09-14       Impact factor: 3.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.